Unknown

Dataset Information

0

Mitochondria Are Potential Targets for the Development of New Drugs Against Neutrophilic Inflammation in Severe Pneumonia Including COVID-19.

ABSTRACT:

SUBMITTER: Vorobjeva NV 

PROVIDER: S-EPMC7878366 | biostudies-literature | 2021

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Mitochondria Are Potential Targets for the Development of New Drugs Against Neutrophilic Inflammation in Severe Pneumonia Including COVID-19.

Vorobjeva Nina V NV   Sud'ina Galina F GF   Chernyak Boris V BV  

Frontiers in pharmacology 20210129

Similar Datasets

Unknown Vascular neutrophilic inflammation and immunothrombosis distinguish severe COVID-19 from influenza pneumonia.
| S-EPMC7753335 | biostudies-literature
Unknown Fluticasone/salmeterol reduces remodelling and neutrophilic inflammation in severe equine asthma.
| S-EPMC5562887 | biostudies-literature
Unknown Nontypeable Haemophilus influenzae infection of pulmonary macrophages drives neutrophilic inflammation in severe asthma.
| S-EPMC9796932 | biostudies-literature
Unknown Discovery of potential imaging and therapeutic targets for severe inflammation in COVID-19 patients.
| S-EPMC8266867 | biostudies-literature
Unknown NADPH oxidases as potential pharmacological targets against increased seizure susceptibility after systemic inflammation.
| S-EPMC5948699 | biostudies-literature
Unknown Better prognosis in females with severe COVID-19 pneumonia: possible role of inflammation as potential mediator.
| S-EPMC7816626 | biostudies-literature
Unknown Machine learning links unresolving secondary pneumonia to mortality in patients with severe pneumonia, including COVID-19.
| S-EPMC10266785 | biostudies-literature
Unknown Searching for potential drugs against SARS-CoV-2 through virtual screening on several molecular targets.
| S-EPMC7876915 | biostudies-literature
Unknown Computational insights into binding mechanism of drugs as potential inhibitors against SARS-CoV-2 targets.
| S-EPMC8404755 | biostudies-literature
Unknown Fenofibrate Attenuates Neutrophilic Inflammation in Airway Epithelia: Potential Drug Repurposing for Cystic Fibrosis.
| S-EPMC5351137 | biostudies-literature